Paul MacDonald Inovio Pharmaceuticals INO-Q COMMENT May 09, 2023

It is too small and volatile.

Paul MacDonald

Unknown

Unlock Rating

$0.838

Stock price when the opinion was issued

Pharma & Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

RISKY

A smaller pharma name. It's a pure spec stock. If you're a young investor, it doesn't hurt to hold one spec stock.

DON'T BUY

It's a spec stock that hasn't delivered.

Most Recent Experts

Kim Bolton

Black Swan Dexteritas

Jim Cramer - Mad Money

CNBC

Chris Blumas

at Raymond James Investment Counsel Ltd.

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Paul MacDonald Inovio Pharmaceuticals INO-Q COMMENT May 09, 2023

You might be interested:

Inovio Pharmaceuticals(INO-Q)

Inovio Pharmaceuticals(INO-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals